20 May 2013
Keywords: Biosimilars market, Europe, USA, Japan, Datamonitor
Article | 29 March 2011
More than 30 branded biologics with sales of $51 billion set to lose patent exclusivity between 2011 and 2015, and uptake of biosimilar versions ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.